Pioneering Soft Matter for Bioimaging and Regenerative Medicine
An AMU-IDUB International Research Team project, financed by the 'Excellence Initiative - Research University' program.
Discover Our MissionOur Research Focus
Advanced Nanocarriers
for Theranostics
We design, fabricate, and characterize innovative lipid-based and hybrid nanocarriers for targeted drug delivery, advanced bioimaging (including MRI), and combined diagnostic/therapeutic (theranostic) applications.
Regenerative Medicine
& Smart Biomaterials
Our research focuses on developing intelligent biomaterials, including functional hydrogels and tissue engineering scaffolds, to promote tissue repair, regeneration (e.g., in cardiac conditions), and wound healing.
Soft Matter
Characterization
We employ a suite of cutting-edge techniques, including Cryo-TEM, NMR, SAXS, and other advanced imaging and scattering methodologies, for high-resolution structural analysis and understanding the dynamics of soft matter systems.
Nanotherapeutics
for Disease Intervention
We engineer targeted nanomedicines, including systems for cancer therapy (e.g., glioblastoma), antibacterial applications to combat resistant strains, and therapies for neurodegenerative and cardiovascular disorders.
Meet the BioSoft Team
Fall BioSoft Meeting 2025
Welcome to the Fall BioSoft International Research Team Meeting 2025, hosted at our Centre on October 29–30, 2025. This meeting convenes the international BioSoft team funded by ID UB UAM (173/02/UAM/0036) and is open to the public. The program features lectures from team members and invited guests on soft matter and its biomedical applications.
Meeting Details
Dates: October 29–30, 2025
Location: NanoBioMedical Centre, Adam Mickiewicz University, Poznań
Led by Dr. Grzegorz Nowaczyk, the BioSoft team includes experts from China, Greece, and Poland, focusing on developing nanoplatforms for MRI and advanced hydrogels for wound healing.
Gallery
Lead Institution
NanoBioMedical Centre
Adam Mickiewicz University
Wszechnicy Piastowskiej 3
61-614 Poznań, Poland
Funding Decision
173/02/UAM/0036